SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Biotron CEO to Review Portfolio and Define Sedrx Strategy

Biotron says its CEO will review the portfolio, define the Sedrx strategy and evaluate asset pathways.

BIT

Related stories